Vitamin D receptor, UVR, and skin cancer: a potential protective mechanism
- PMID: 18787544
- PMCID: PMC9017605
- DOI: 10.1038/jid.2008.249
Vitamin D receptor, UVR, and skin cancer: a potential protective mechanism
Abstract
More than 1 million skin cancers occur annually in the United States--of which 80% are basal-cell carcinoma (BCC), 16% are squamous-cell carcinoma (SCC), and 4% are melanomas--making skin cancer by far the most common cancer (Greenlee et al., 2001). UVR is the major etiologic agent. UV wavelengths shorter than 280 nm (UVC) are absorbed by the ozone layer and do not reach the earth. UV wavelengths longer than 320 nm (UVA) have limited ability to induce the characteristic mutations in DNA seen in epidermal cancers. Thus, UVB, with a spectrum between 280 and 320 nm, is the major cause of these cancers (Freeman et al., 1989), but this is the same spectrum required for vitamin D production in the skin. Is there a link?
Conflict of interest statement
CONFLICT OF INTEREST
The author states no conflict of interest.
Comment on
-
Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis.J Invest Dermatol. 2008 Oct;128(10):2508-17. doi: 10.1038/jid.2008.131. Epub 2008 May 29. J Invest Dermatol. 2008. PMID: 18509362 Free PMC article.
Similar articles
-
The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.Adv Exp Med Biol. 2020;1268:257-283. doi: 10.1007/978-3-030-46227-7_13. Adv Exp Med Biol. 2020. PMID: 32918223 Free PMC article. Review.
-
The Vitamin D Receptor as Tumor Suppressor in Skin.Adv Exp Med Biol. 2020;1268:285-306. doi: 10.1007/978-3-030-46227-7_14. Adv Exp Med Biol. 2020. PMID: 32918224 Review.
-
The vitamin D receptor: a tumor suppressor in skin.Adv Exp Med Biol. 2014;810:282-302. doi: 10.21236/ada614241. Adv Exp Med Biol. 2014. PMID: 25207372 Free PMC article. Review.
-
UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.Adv Exp Med Biol. 2017;996:27-40. doi: 10.1007/978-3-319-56017-5_3. Adv Exp Med Biol. 2017. PMID: 29124688 Review.
-
Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.Adv Exp Med Biol. 2014;810:208-33. doi: 10.1007/978-1-4939-0437-2_12. Adv Exp Med Biol. 2014. PMID: 25207368 Review.
Cited by
-
Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy.Int J Mol Sci. 2022 Aug 2;23(15):8575. doi: 10.3390/ijms23158575. Int J Mol Sci. 2022. PMID: 35955731 Free PMC article. Review.
-
Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives.Cell Biochem Biophys. 2020 Jun;78(2):165-180. doi: 10.1007/s12013-020-00913-6. Epub 2020 May 22. Cell Biochem Biophys. 2020. PMID: 32441029 Free PMC article. Review.
-
Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas.Cancer Prev Res (Phila). 2011 May;4(5):744-51. doi: 10.1158/1940-6207.CAPR-10-0285. Epub 2011 Mar 24. Cancer Prev Res (Phila). 2011. PMID: 21436386 Free PMC article.
-
Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin.J Invest Dermatol. 2024 Oct;144(10):2145-2161. doi: 10.1016/j.jid.2024.04.022. Epub 2024 Jul 12. J Invest Dermatol. 2024. PMID: 39001720 Review.
-
The serum vitamin D metabolome: What we know and what is still to discover.J Steroid Biochem Mol Biol. 2019 Feb;186:4-21. doi: 10.1016/j.jsbmb.2018.09.003. Epub 2018 Sep 8. J Steroid Biochem Mol Biol. 2019. PMID: 30205156 Free PMC article. Review.
References
-
- Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM et al. (1998) Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 110:885–8 - PubMed
-
- Aszterbaum M, Epstein J, Oro A, Douglas V, LeBoit PE, Scott MP et al. (1999) Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 5:1285–91 - PubMed
-
- Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864–70 - PubMed
-
- Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633–7 - PubMed
-
- Berg RJ, Rebel H, van der Horst GT, van Kranen HJ, Mullenders LH, van Vloten WA et al. (2000) Impact of global genome repair versus transcription-coupled repair on ultraviolet carcinogenesis in hairless mice. Cancer Res 60:2858–63 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials